Literature DB >> 24334801

Effect of preoperative antibiotic prophylaxis on surgical site infections complicating cardiac surgery.

Renato Finkelstein1, Galit Rabino, Tania Mashiach, Yaron Bar-El, Zvi Adler, Victor Kertzman, Oved Cohen, Simcha Milo.   

Abstract

OBJECTIVE: To evaluate the effect of an optimized policy for antibiotic prophylaxis on surgical site infection (SSI) rates in cardiac surgery.
DESIGN: Prospective cohort study.
SETTING: Tertiary medical center in Israel.
METHODS: SSIs were recorded during a 10-year study period and ascertained through routine surveillance using the National Healthcare Safety Network (NHSN) methodology. Multivariable analyses were conducted to determine which significant covariates, including the administration of preoperative prophylaxis, affected these outcomes.
RESULTS: A total of 2,637 of 3,170 evaluated patients were included, and the overall SSI rate was 8.4%. A greater than 50% reduction in SSI rates was observed in the last 4 years of the study. Overall and site-specific infection rates were similar for patients receiving cefazolin or vancomycin. SSIs developed in 206 (8.1%) of the 2,536 patients who received preoperative prophylaxis (within 2 hours of the first incision) compared with 14 (13.9%) of 101 patients who received antibiotic prophylaxis at a different time (P = .04; odds ratio [OR], 1.8; 95% confidence interval [CI], 1.0-3.3). After accounting for covariates, preoperative hospital stay (5 days or more), an NHSN risk category (2 or 3), age (60 years or more), surgeon's role, and the period of measurement were significantly associated with SSIs. Emergency surgery, age, surgeon's role, and nonpreoperative prophylaxis were found to be independent predictors of superficial SSI.
CONCLUSIONS: We observed a progressive and significant decrease in SSI rates after the implementation of an infection control program that included an optimized policy of preoperative prophylaxis in cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24334801     DOI: 10.1086/674386

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  4 in total

Review 1.  A Roadmap for Reducing Cardiac Device Infections: a Review of Epidemiology, Pathogenesis, and Actionable Risk Factors to Guide the Development of an Infection Prevention Program for the Electrophysiology Laboratory.

Authors:  Westyn Branch-Elliman
Journal:  Curr Infect Dis Rep       Date:  2017-08-16       Impact factor: 3.725

2.  Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass.

Authors:  J Lanoiselée; P J Zufferey; S Hodin; N Tamisier; L Gergelé; J C Palao; S Campisi; S Molliex; J Morel; X Delavenne; E Ollier
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

3.  Surgical site infection in patients submitted to heart transplantation.

Authors:  Jussara Aparecida Souza do Nascimento Rodrigues; Renata Eloah de Lucena Ferretti-Rebustini; Vanessa de Brito Poveda
Journal:  Rev Lat Am Enfermagem       Date:  2016-08-29

4.  Optimizing Prophylactic Antibiotic Practice for Cardiothoracic Surgery by Pharmacists' Effects.

Authors:  Ling Zhou; Jingjing Ma; Jie Gao; Shiqi Chen; Jianan Bao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.